Loading...
Loading...
JP Morgan has raised the price target on Boston Scientific Corporation
BSX from $7 to $8 and maintains its Underweight rating.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In: Price TargetAnalyst Ratingsboston scientific corporationHealth CareHealth Care EquipmentJP Morgan
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
